The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
Claire Scanlan
Advertisement
Claire Scanlan is process development scientist at EMD Millipore, 290 Concord Road, Billerica, MA 01821.
Articles by Claire Scanlan
Antibody fragments pose unique challenges in recovery, purification, and formulation.
Advertisement
Latest Updated Articles
Advertisement
Advertisement